Clotblog with Dr Samuel GoldhaberView all posts »
Focus on AF in Latin America with the GARFIELD registryJan 22, 2013 15:25 EST
The perspective from Mexico, Chile, Argentina, and Brazil on AF in the "real-life" setting—as opposed to the controlled environment of a clinical trial—is an important part of this ambitious study, which seeks to enroll 55 000 people worldwide. Find out more.
Kakkar AK, et al. International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD). Am Heart J 2012;163:13-19. Abstract